Skip to content

Drug interactions

Indacaterol inhaled + Ziprasidone

Severity: Moderate

Indacaterol inhaled and Ziprasidone: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Indacaterol, a long-acting beta-2 agonist, can cause tachycardia, hypokalemia and QT prolongation, which may add to the QT effect of ziprasidone. The risk of ventricular arrhythmia is greater in patients with other risk factors.

What this interaction means in plain words

Indacaterol inhaled and Ziprasidone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Low

Why it happens

Additive QT prolongation, with beta-agonist-induced hypokalemia further increasing arrhythmia risk.

What to do

Monitor ECG and serum potassium in patients with cardiac risk factors, and correct electrolyte abnormalities. Consider alternatives to ziprasidone in patients with known QT prolongation.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Indacaterol inhaled and Ziprasidone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Indacaterol inhaled with Ziprasidone?

MediHelp rates the interaction as moderate. Indacaterol inhaled and Ziprasidone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Indacaterol, a long-acting beta-2 agonist, can cause tachycardia, hypokalemia and QT prolongation, which may add to the QT effect of ziprasidone. The risk of ventricular arrhythmia is greater in patients with other risk factors.

How serious is the interaction between Indacaterol inhaled and Ziprasidone?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor ECG and serum potassium in patients with cardiac risk factors, and correct electrolyte abnormalities. Consider alternatives to ziprasidone in patients with known QT prolongation.

What other medicines interact with Ziprasidone?

MediHelp also lists interactions of Ziprasidone with, for example, Amiodarone, Amitriptyline, Arsenic trioxide. The full list is on the Ziprasidone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in